Generic Name and Formulations:
Flucytosine 250mg, 500mg; caps.
Bausch Health Companies Inc.
Indications for ANCOBON:
In combination with amphotericin B: Candida infections in septicemia, endocarditis, UTIs and pulmonary infections; cryptococcus infections in meningitis, pulmonary, septicemia, and UTIs.
Adults and Children:
50–150mg/kg per day given in divided doses every 6 hours. To minimize GI upset, give a few capsules at a time over 15 minutes. Renal impairment: give initial dose at lower range.
Use extreme caution in patients with impaired renal function.
Renal or hepatic impairment. Monitor electrolytes, blood count, renal and hepatic function before and during therapy. Bone marrow depression (eg, hematologic disease, history or currently treated with radiation or bone marrow depressants). Pregnancy (Cat.C). Nursing mothers.
Antagonized by cytosine arabinoside. May be potentiated by drugs that impair glomerular filtration.
Cardiac events, chest pain, dyspnea, GI upset, abdominal pain, hepatic dysfunction, elevated creatinine and BUN, blood dyscrasias, ataxia, headache, confusion, fatigue, hypoglycemia, hypokalemia, rash, allergic reactions, others.
Renal and Urology News Articles
- Kidney Damage in Younger Adults Tied to NSAID Use
- Dialysis and Transplant Patients at Increased Risk for Cancer Death
- Guidelines Updated for Pulmonary Arterial Hypertension in Adults
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Darolutamide Improves Metastasis-Free Survival in CRPC
- Prednisone to Blame for ERA 223 Trial Failure?
- Clinicians Somewhat Favor Shared Decision-Making in Older mCRPC Patients
- Higher Push-Up Capacity Linked to Lower Incidence of CVD Events
- Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)